Kovack Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$681K Sell
10,877
-999
-8% -$62.6K 0.07% 260
2025
Q1
$715K Buy
11,876
+1
+0% +$60 0.08% 228
2024
Q4
$693K Buy
11,875
+1,251
+12% +$73K 0.07% 239
2024
Q3
$629K Sell
10,624
-449
-4% -$26.6K 0.07% 254
2024
Q2
$621K Buy
11,073
+1
+0% +$56 0.07% 258
2024
Q1
$649K Buy
11,072
+49
+0.4% +$2.87K 0.08% 214
2023
Q4
$595K Sell
11,023
-1,179
-10% -$63.6K 0.07% 264
2023
Q3
$592K Sell
12,202
-4,031
-25% -$195K 0.08% 224
2023
Q2
$916K Sell
16,233
-1,682
-9% -$95K 0.12% 166
2023
Q1
$967K Sell
17,915
-144
-0.8% -$7.77K 0.13% 154
2022
Q4
$949K Sell
18,059
-6,109
-25% -$321K 0.14% 151
2022
Q3
$1.14M Sell
24,168
-2,162
-8% -$102K 0.17% 136
2022
Q2
$1.33M Sell
26,330
-12,386
-32% -$625K 0.18% 127
2022
Q1
$2.36M Buy
38,716
+460
+1% +$28K 0.24% 87
2021
Q4
$2.52M Buy
38,256
+3,736
+11% +$246K 0.24% 94
2021
Q3
$2.17M Sell
34,520
-58
-0.2% -$3.64K 0.24% 110
2021
Q2
$2.08M Sell
34,578
-4,932
-12% -$297K 0.24% 110
2021
Q1
$2.18M Sell
39,510
-71,892
-65% -$3.96M 0.28% 94
2020
Q4
$6.08M Buy
111,402
+2,160
+2% +$118K 0.87% 13
2020
Q3
$5.46M Sell
109,242
-15,684
-13% -$783K 0.97% 15
2020
Q2
$5.51M Buy
124,926
+16,086
+15% +$710K 1.07% 12
2020
Q1
$4.09M Buy
108,840
+87,144
+402% +$3.27M 0.94% 13
2019
Q4
$956K Buy
21,696
+588
+3% +$25.9K 0.17% 149
2019
Q3
$870K Buy
21,108
+1,140
+6% +$47K 0.18% 147
2019
Q2
$801K Sell
19,968
-582
-3% -$23.3K 0.18% 133
2019
Q1
$793K Buy
20,550
+4,260
+26% +$164K 0.2% 129
2018
Q4
$543K Buy
16,290
+1,278
+9% +$42.6K 0.16% 156
2018
Q3
$569K Buy
15,012
+438
+3% +$16.6K 0.15% 175
2018
Q2
$487K Buy
14,574
+648
+5% +$21.7K 0.14% 181
2018
Q1
$429K Buy
13,926
+2,124
+18% +$65.4K 0.11% 218
2017
Q4
$341K Sell
11,802
-3,948
-25% -$114K 0.09% 273
2017
Q3
$439K Buy
15,750
+330
+2% +$9.2K 0.15% 166
2017
Q2
$428K Buy
15,420
+2,400
+18% +$66.6K 0.14% 182
2017
Q1
$329K Buy
13,020
+900
+7% +$22.7K 0.13% 178
2016
Q4
$269K Buy
12,120
+1,830
+18% +$40.6K 0.13% 176
2016
Q3
$249K Buy
+10,290
New +$249K 0.12% 193